Association of serum YKL-40 levels with urinary albumin excretion rate in young Japanese patients with type 1 diabetes mellitus

Endocrine Journal

Volumn 60, Issue 1, 2013, Pages 73-79

  Sakamoto, Fumie ^a   Katakami, Naoto ^a   Kaneto, Hideaki ^a   Yasuda, Tetsuyuki ^a   Takahara, Mitsuyoshi ^a   Miyashita, Kazuyuki ^a   Kuroda, Akio ^b   Matsuhisa, Munehide ^b   Kosugi, Keisuke ^c   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c OSAKA POLICE HOSPITAL   (Japan)

Author keywords

Albuminuria; Diabetic retinopathy; Type 1 diabetes; YKL 40

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHITINASE; PROTEIN YKL 40; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC MACROANGIOPATHY; DIABETIC MICROANGIOPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPANESE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; URINARY EXCRETION;

ADIPOKINES; ADULT; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; HUMANS; LECTINS; MALE;

EID: 84873516655     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0238     Document Type: Article

References (27)

1. Johansen JS (2006) Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodeling, fibrosis and cancer. Dan Med Bull 53: 172-209.
2. Johansen JS, Stoltenberg M, Hansen M, Florescu A, Hørslev-Petersen K (1999) Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity. Rheumatology (Oxford) 38: 618-626.
3. Johansen JS, Bojesen SE, Mylin AK, Frikke-Schmidt R, Price PA (2009) Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population. J Clin Oncol 27: 572-578.
4. Kastrup J, Johansen JS, Winkel P, Hansen JF, Hildebrandt P; CLARICOR Trial Group (2009) High serum YKL-40 concentration is associated with cardiovascular and allcause mortality in patients with stable coronary artery disease. Eur Heart J 30: 1066-1072.
5. Rathcke CN, Johansen JS, Vestergaard H (2006) YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance. Inflamm Res 55: 53-59.
6. Nielsen AR, Erikstrup C, Johansen JS, Fischer CP, Plomgaard P (2008) Plasma YKL-40: a BMIindependent marker of type 2 diabetes. Diabetes 57: 3078-3082.
7. Yasuda T, Kaneto H, Katakami N, Kuroda A, Matsuoka TA (2011) YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patients. Diabetes Res Clin Pract 91: e50-e52.
8. Rathcke CN, Persson F, Tarnow L, Rossing P, Vestergaard H (2009) YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Diabetes Care 32: 323-328.
9. Kawamori R (1992) Prevalence of carotid atherosclerosis in diabetic patients: ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care 15: 1290-1294.
10. The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus (2010) Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. J Diabetes Invest 1: 212-228.
11. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K; Collaborators developing the Japanese equation for estimated GFR (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992.
12. Reutens AT, Atkins RC (2011) Epidemiology of diabetic nephropathy. Contrib Nephrol 170: 1-7.
13. Kawasaki E, Matsuura N, Eguchi K (2006) Type 1 diabetes in Japan. Diabetologia 49: 828-836.
14. Egawa H, Tanabe K, Fukushima N, Date H, Sugitani A (2012) Current status of organ transplantation in Japan. Am J Transplant 12: 523-530.
15. Røndbjerg AK, Omerovic E, Vestergaard H (2011) YKL-40 levels are independently associated with albuminuria in type 2 diabetes. Cardiovasc Diabetol 10: 54.
16. Schram MT, Chaturvedi N, Schalkwijk CG, Fuller JH, Stehouwer CD (2005) Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetologia 48: 370-378.
17. Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD (2008) Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate. Diabetes Care 31: 1170-1176.
18. Lin J, Glynn RJ, Rifai N, Manson JE, Ridker PM (2008) Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial. Diabetes Care 31: 2338-2343.
19. Klein BE, Knudtson MD, Tsai MY, Klein R (2009) The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol 127: 1175-1182.
20. Rossing P, Hougaard P, Parving HH (2002) Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 25: 859-864.
21. Molitch ME, Steffes M, Sun W, Rutledge B, Cleary P; Epidemiology of Diabetes Interventions and Complications Study Group (2010) Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care 33: 1536-1543.
22. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B; HOPE Study Investigators (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286: 421-426.
23. Kastrup J (2012) Can YKL-40 be a new inflammatory biomarker in cardiovascular disease? Immunobiology 217: 483-491.
24. Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T (2010) Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 211:589-595.
25. Marcovecchio ML, Giannini C, Widmer B, Dalton RN, Martinotti S (2008) C-reactive protein in relation to the development of microalbuminuria in type 1 diabetes: the Oxford Regional Prospective Study. Diabetes Care 31: 974-976.
26. Devaraj S, Cheung AT, Jialal I, Griffen SC, Nguyen D (2007) Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes 56: 2790-2796.
27. Nielsen AR, Plomgaard P, Krabbe KS, Johansen JS, Pedersen BK (2011) IL-6, but not TNF-α, increases plasma YKL-40 in human subjects. Cytokine 55: 152-155.